Immunology of bovine respiratory syncytial virus in calves

Molecular Immunology

Volumn 66, Issue 1, 2015, Pages 48-56

  Guzman, Efrain ^a   Taylor, Geraldine ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Calves; Immunity; Pathogenesis; Respiratory disease; Respiratory syncytial virus; Vaccines

Indexed keywords

EPITOPE; HYBRID PROTEIN; INTERFERON; MONOCLONAL ANTIBODY; PATTERN RECOGNITION RECEPTOR; RESPIRATORY SYNCYTIAL VIRUS VACCINE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VIRUS PROTEIN; VIRUS FUSION PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; B LYMPHOCYTE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; CALF (BOVINE); CD8+ T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RESPIRATORY TRACT DISEASE; REVIEW; T LYMPHOCYTE; VACCINATION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS IMMUNITY; ANIMAL; BOVINE; BOVINE RESPIRATORY DISEASE COMPLEX; DISEASE MODEL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

ANIMALIA; BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; DISEASE MODELS, ANIMAL; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL FUSION PROTEINS;

EID: 84924612131     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.12.004     Document Type: Review

References (135)

1. Antonis A.F., Claassen E.A., Hensen E.J., de Groot R.J., de Groot-Mijnes J.D., Schrijver R.S., van der Most R.G. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. Vaccine 2006, 24:1551-1561.
2. Antonis A.F., de Jong M.C., van der Poel W.H., van der Most R.G., Stockhofe-Zurwieden N., Kimman T., Schrijver R.S. Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence. J. Gen. Virol. 2010, 91:2497-2506.
3. Antonis A.F., Schrijver R.S., Daus F., Steverink P.J., Stockhofe N., Hensen E.J., Langedijk J.P., van der Most R.G. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J. Virol. 2003, 77:12067-12073.
4. Aoyagi M., Shimojo N., Sekine K., Nishimuta T., Kohno Y. Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin. Exp. Immunol. 2003, 131:312-317.
5. Arbiza J., Taylor G., Lopez J.A., Furze J., Wyld S., Whyte P., Stott E.J., Wertz G., Sullender W., Trudel M., et al. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 1992, 73(Pt 9):2225-2234.
6. Atreya P.L., Kulkarni S. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human M×A. Virology 1999, 261:227-241.
7. Awomoyi A.A., Rallabhandi P., Pollin T.I., Lorenz E., Sztein M.B., Boukhvalova M.S., Hemming V.G., Blanco J.C., Vogel S.N. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J. Immunol. 2007, 179:3171-3177.
8. Barik S. Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr. Top. Microbiol. Immunol. 2013, 372:173-191.
9. Becker S., Quay J., Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 1991, 147:4307-4312.
10. Bermejo-Martin J.F., Tenorio A., Ortiz de Lejarazu R., Eiros J.M., Matias V., Dominguez-Gil M., Pino M., Alonso A., Blanco-Quiros A., Arranz E., Ardura J. Similar cytokine profiles in response to infection with respiratory syncytial virus type A and type B in the upper respiratory tract in infants. Intervirology 2008, 51:112-115.
11. Bertho N., Marquet F., Pascale F., Kang C., Bonneau M., Schwartz-Cornil I. Steady state pig dendritic cells migrating in skin draining pseudo-afferent lymph are semi-mature. Vet. Immunol. Immunopathol. 2011, 144:430-436.
12. Bhoj V.G., Sun Q., Bhoj E.J., Somers C., Chen X., Torres J.P., Mejias A., Gomez A.M., Jafri H., Ramilo O., Chen Z.J. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14046-14051.
13. Boelen A., Andeweg A., Kwakkel J., Lokhorst W., Bestebroer T., Dormans J., Kimman T. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Vaccine 2000, 19:982-991.
14. Bossert B., Conzelmann K.K. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 2002, 76:4287-4293.
15. Bossert B., Marozin S., Conzelmann K.K. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 2003, 77:8661-8668.
16. Boysen P., Storset A.K. Bovine natural killer cells. Vet. Immunol. Immunopathol. 2009, 130:163-177.
17. Bujdoso R., Hopkins J., Dutia B.M., Young P., McConnell I. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J. Exp. Med. 1989, 170:1285-1301.
18. Bukreyev A., Yang L., Fricke J., Cheng L., Ward J.M., Murphy B.R., Collins P.L. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J. Virol. 2008, 82:12191-12204.
19. Buza J., Benjamin P., Zhu J., Wilson H.L., Lipford G., Krieg A.M., Babiuk L.A., Mutwiri G.K. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands. Vet. Immunol. Immunopathol. 2008, 126:273-282.
20. Connors M., Kulkarni A.B., Firestone C.Y., Holmes K.L., Morse H.C., Sotnikov A.V., Murphy B.R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 1992, 66:7444-7451.
21. Cronkite E.P., Jansen C.R., Cottier H., Rai K., Sipe C.R. Lymphocyte production measured by extracorporeal irradiation, cannulation, and labeling techniques. Ann. N. Y. Acad. Sci. 1964, 113:566-577.
22. Cubillos-Zapata C., Guzman E., Turner A., Gilbert S.C., Prentice H., Hope J.C., Charleston B. Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo. J. Virol. 2011, 85:9385-9394.
23. Das S., Palmer O.P., Leight W.D., Surowitz J.B., Pickles R.J., Randell S.H., Buchman C.A. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Laryngoscope 2005, 115:764-768.
24. de Graaff P.M., de Jong E.C., van Capel T.M., van Dijk M.E., Roholl P.J., Boes J., Luytjes W., Kimpen J.L., van Bleek G.M. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 2005, 175:5904-5911.
25. De Weerd W., Twilhaar W.N., Kimpen J.L. T cell subset analysis in peripheral blood of children with RSV bronchiolitis. Scand. J. Infect. Dis. 1998, 30:77-80.
26. Dodd J., Riffault S., Kodituwakku J.S., Hayday A.C., Openshaw P.J. Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease. J. Immunol. 2009, 182:1174-1181.
27. Durbin R.K., Kotenko S.V., Durbin J.E. Interferon induction and function at the mucosal surface. Immunol. Rev. 2013, 255:25-39.
28. Ehrich W.E. Simultaneous renal and hepatic excretion of water, cyanol, and azofuchsin I in rabbits. J. Exp. Med. 1942, 76:349-355.
29. El-Sahly H.M., Atmar R.L., Glezen W.P., Greenberg S.B. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2000, 31:96-100.
30. Ellis J.A., Gow S.P., Mahan S., Leyh R. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves. J. Am. Vet. Med. Assoc. 2013, 243:1602-1608.
31. Fach S.J., Meyerholz D.K., Gallup J.M., Ackermann M.R., Lehmkuhl H.D., Sacco R.E. Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 And IL-10 gene transcripts. Viral Immunol. 2007, 20:119-130.
32. Fach S.J., Olivier A., Gallup J.M., Waters T.E., Ackermann M.R., Lehmkuhl H.D., Sacco R.E. Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet. Immunol. Immunopathol. 2010, 136:55-64.
33. Finn J.A., Crowe J.E. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr. Opin. Immunol. 2013, 25:613-618.
34. Fishaut M., Tubergen D., McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J. Pediatr. 1980, 96:179-186.
35. Fogg M.H., Parsons K.R., Thomas L.H., Taylor G. Identification of CD4+ T cell epitopes on the fusion (F) and attachment (G) proteins of bovine respiratory syncytial virus (BRSV). Vaccine 2001, 19:3226-3240.
36. Fryzek J.P., Martone W.J., Groothuis J.R. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study. Adv. Ther. 2011, 28:195-201.
37. Fuentes S., Tran K.C., Luthra P., Teng M.N., He B. Function of the respiratory syncytial virus small hydrophobic protein. J. Virol. 2007, 81:8361-8366.
38. Furze J.M., Roberts S.R., Wertz G.W., Taylor G. Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity. Virology 1997, 231:48-58.
39. Gaddum R.M., Cook R.S., Furze J.M., Ellis S.A., Taylor G. Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology 2003, 108:220-229.
40. Gaddum R.M., Cook R.S., Thomas L.H., Taylor G. Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology 1996, 88:421-427.
41. Gershwin L.J. Immunology of bovine respiratory syncytial virus infection of cattle. Comp. Immunol. Microbiol. Infect. Dis. 2012, 35:253-257.
42. Gershwin L.J., Anderson M.L., Wang C., Berghaus L.J., Kenny T.P., Gunther R.A. Assessment of IgE response and cytokine gene expression in pulmonary efferent lymph collected after ovalbumin inhalation during experimental infection of calves with bovine respiratory syncytial virus. Am. J. Vet. Res. 2011, 72:134-145.
43. Gershwin L.J., Schelegle E.S., Gunther R.A., Anderson M.L., Woolums A.R., Larochelle D.R., Boyle G.A., Friebertshauser K.E., Singer R.S. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 1998, 16:1225-1236.
44. Graham B.S. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol. Rev. 2011, 239:149-166.
45. Graham B.S., Henderson G.S., Tang Y.W., Lu X., Neuzil K.M., Colley D.G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 1993, 151:2032-2040.
46. Groskreutz D.J., Monick M.M., Powers L.S., Yarovinsky T.O., Look D.C., Hunninghake G.W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J. Immunol. 2006, 176:1733-1740.
47. Guzman E., Cubillos-Zapata C., Cottingham M.G., Gilbert S.C., Prentice H., Charleston B., Hope J.C. Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation. J. Virol. 2012, 86:5452-5466.
48. Guzman E., Hope J., Taylor G., Smith A.L., Cubillos-Zapata C., Charleston B. Bovine gammadelta T cells are a major regulatory T cell subset. J. Immunol. 2014, 193:208-222.
49. Haeberle H.A., Takizawa R., Casola A., Brasier A.R., Dieterich H.J., Van Rooijen N., Gatalica Z., Garofalo R.P. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 2002, 186:1199-1206.
50. Hall C.B., Kopelman A.E., Douglas R.G., Geiman J.M., Meagher M.P. Neonatal respiratory syncytial virus infection. N. Engl. J. Med. 1979, 300:393-396.
51. Hall C.B., Powell K.R., MacDonald N.E., Gala C.L., Menegus M.E., Suffin S.C., Cohen H.J. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 1986, 315:77-81.
52. Hall J.G., Morris B. The output of cells in lymph from the popliteal node of sheep. Quart. J. Exp. Physiol. Cogn. Med. Sci. 1962, 47:360-369.
53. Hanada N., Morishima T., Nishikawa K., Isomura S., Nagai Y. Interferon-mediated self-limiting growth of respiratory syncytial virus in mouse embryo cells. J. Med. Virol. 1986, 20:363-370.
54. Harcourt J., Alvarez R., Jones L.P., Henderson C., Anderson L.J., Tripp R.A. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J. Immunol. 2006, 176:1600-1608.
55. Harker J.A., Yamaguchi Y., Culley F.J., Tregoning J.S., Openshaw P.J. Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system. J. Virol. 2014, 88:604-611.
56. Heidema J., Lukens M.V., van Maren W.W., van Dijk M.E., Otten H.G., van Vught A.J., van der Werff D.B., van Gestel S.J., Semple M.G., Smyth R.L., Kimpen J.L., van Bleek G.M. CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J. Immunol. 2007, 179:8410-8417.
57. Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H.H., Mertens P.P., Breard E., Sailleau C., Zientara S., Schwartz-Cornil I. Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 2009, 83:8789-8799.
58. Hope J.C., Guzman E., Cubillos-Zapata C., Stephens S.A., Gilbert S.C., Prentice H., Sopp P., Howard C.J., Charleston B. Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin. Vaccine 2012, 30:2357-2367.
59. Hope J.C., Howard C.J., Prentice H., Charleston B. Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle. Nat. Protoc. 2006, 1:982-987.
60. Howard C.J., Sopp P., Brownlie J., Kwong L.S., Parsons K.R., Taylor G. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J. Immunol. 1997, 159:5372-5382.
61. Howard C.J., Sopp P., Parsons K.R., Finch J. In vivo depletion of BoT4 (CD4) and of non-T4/T8 lymphocyte subsets in cattle with monoclonal antibodies. Eur. J. Immunol. 1989, 19:757-764.
62. Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
63. Ionac M. One technique, two approaches, and results: thoracic duct cannulation in small laboratory animals. Microsurgery 2003, 23:239-245.
64. Jin H., Zhou H., Cheng X., Tang R., Munoz M., Nguyen N. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 2000, 273:210-218.
65. Johnson J.E., Gonzales R.A., Olson S.J., Wright P.F., Graham B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol. Inc. 2007, 20:108-119.
66. Johnson T.R., Johnson C.N., Corbett K.S., Edwards G.C., Graham B.S. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PloS One 2011, 6:e16458.
67. Johnson T.R., McLellan J.S., Graham B.S. Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. J. Virol. 2012, 86:1339-1347.
68. Kalina W.V., Woolums A.R., Berghaus R.D., Gershwin L.J. Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 2004, 22:1465-1474.
69. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89:405-421.
70. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrott R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89:422-434.
71. Kimman T.G., Sol J., Westenbrink F., Straver P.J. A severe outbreak of respiratory-tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet. Quart. 1989, 11:250-253.
72. Kimman T.G., Straver P.J., Zimmer G.M. Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: morphologic and serologic findings. Am. J. Vet. Res. 1989, 50:684-693.
73. Kimman T.G., Westenbrink F. Immunity to human and bovine respiratory syncytial virus. Arch. Virol. 1990, 112:1-25.
74. Kimman T.G., Westenbrink F., Schreuder B.E., Straver P.J. Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J. Clin. Microbiol. 1987, 25:1097-1106.
75. Kotelkin A., Belyakov I.M., Yang L., Berzofsky J.A., Collins P.L., Bukreyev A. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response. J. Virol. 2006, 80:5958-5967.
76. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1:398-401.
77. Leisner C., Loeth N., Lamberth K., Justesen S., Sylvester-Hvid C., Schmidt E.G., Claesson M., Buus S., Stryhn A. One-pot, mix-and-read peptide-MHC tetramers. PloS One 2008, 3:e1678.
78. Levast B., Schulz S., Hurk S., Gerdts V. Animal models for neonatal diseases in humans. Vaccine 2013, 31:2489-2499.
79. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
80. Li F., Zhu H., Sun R., Wei H., Tian Z. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J. Virol. 2012, 86:2251-2258.
81. Li Z., Gabbard J.D., Mooney A., Chen Z., Tompkins S.M., He B. Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice. J. Virol. 2013, 87:9604-9609.
82. Lin Y., Bright A.C., Rothermel T.A., He B. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 2003, 77:3371-3383.
83. Lizundia R., Sauter K.S., Taylor G., Werling D. Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun. 2008, 14:223-231.
84. Lo M.S., Brazas R.M., Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 2005, 79:9315-9319.
85. Lotz M.T., Moore M.L., Peebles R.S. Respiratory syncytial virus and reactive airway disease. Curr. Top. Microbiol. Immunol. 2013, 372:105-118.
86. Lukacs N.W., Smit J.J., Mukherjee S., Morris S.B., Nunez G., Lindell D.M. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 2010, 185:2231-2239.
87. Marr N., Turvey S.E. Role of human TLR4 in respiratory syncytial virus-induced NF-kappaB activation, viral entry and replication. Innate Immun. 2012, 18:856-865.
88. McGill J.L., Nonnecke B.J., Lippolis J.D., Reinhardt T.A., Sacco R.E. Differential chemokine and cytokine production by neonatal bovine gammadelta T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection. Immunology 2013, 139:227-244.
89. McInnes E., Sopp P., Howard C.J., Taylor G. Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology 1999, 96:396-403.
90. Meyer G., Deplanche M., Schelcher F. Human and bovine respiratory syncytial virus vaccine research and development. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31:191-225.
91. Murawski M.R., Bowen G.N., Cerny A.M., Anderson L.J., Haynes L.M., Tripp R.A., Kurt-Jones E.A., Finberg R.W. Respiratory syncytial virus activates innate immunity through toll-like receptor 2. J. Virol. 2009, 83:1492-1500.
92. Norimine J., Han S., Brown W.C. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers. Immunogenetics 2006, 58:726-739.
93. Piedra P.A., Wyde P.R., Castleman W.L., Ambrose M.W., Jewell A.M., Speelman D.J., Hildreth S.W. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 1993, 11:1415-1423.
94. Polack F.P., Irusta P.M., Hoffman S.J., Schiatti M.P., Melendi G.A., Delgado M.F., Laham F.R., Thumar B., Hendry R.M., Melero J.A., Karron R.A., Collins P.L., Kleeberger S.R. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8996-9001.
95. Prince G.A., Curtis S.J., Yim K.C., Porter D.D. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 2001, 82:2881-2888.
96. Prince G.A., Jenson A.B., Hemming V.G., Murphy B.R., Walsh E.E., Horswood R.L., Chanock R.M. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J. Virol. 1986, 57:721-728.
97. Rosenberg H.F., Domachowske J.B. Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr. Med. Chem. 2012, 19:1424-1431.
98. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79:3350-3357.
99. Sacco R.E., Nonnecke B.J., Palmer M.V., Waters W.R., Lippolis J.D., Reinhardt T.A. Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3. PloS One 2012, 7:e33074.
100. Scheerlinck J.P., Gekas S., Yen H.H., Edwards S., Pearse M., Coulter A., Sutton P. Local immune responses following nasal delivery of an adjuvanted influenza vaccine. Vaccine 2006, 24:3929-3936.
101. Schlender J., Bossert B., Buchholz U., Conzelmann K.K. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 2000, 74:8234-8242.
102. Schmitz N., Kurrer M., Bachmann M.F., Kopf M. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 2005, 79:6441-6448.
103. Schreiber P., Matheise J.P., Dessy F., Heimann M., Letesson J.J., Coppe P., Collard A. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J. Vet. Med. B. Infect. Dis. Vet. Public Health 2000, 47:535-550.
104. Schwartz-Cornil I., Epardaud M., Bonneau M. Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nat. Protoc. 2006, 1:874-879.
105. Segovia J., Sabbah A., Mgbemena V., Tsai S.Y., Chang T.H., Berton M.T., Morris I.R., Allen I.C., Ting J.P., Bose S. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One 2012, 7:e29695.
106. Shaw C.A., Galarneau J.R., Bowenkamp K.E., Swanson K.A., Palmer G.A., Palladino G., Markovits J.E., Valiante N.M., Dormitzer P.R., Otten G.R. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease. Vaccine 2013, 31:306-312.
107. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 2001, 19:3331-3346.
108. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 2004, 78:4363-4369.
109. Spann K.M., Tran K.C., Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 2005, 79:5353-5362.
110. Stilwell G., Matos M., Carolino N., Lima M.S. Effect of a quadrivalent vaccine against respiratory virus on the incidence of respiratory disease in weaned beef calves. Prev. Vet. Med. 2008, 85:151-157.
111. Stott E.J., Taylor G. Respiratory syncytial virus. Brief review. Arch. Virol. 1985, 84:1-52.
112. Svitek N., Hansen A.M., Steinaa L., Saya R., Awino E., Nielsen M., Buus S., Nene V. Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle. Vet. Res. 2014, 45:50.
113. Taylor G. Bovine model of respiratory syncytial virus infection. Curr. Top. Microbiol. Immunol. 2013, 372:327-345.
114. Taylor G., Rijsewijk F.A., Thomas L.H., Wyld S.G., Gaddum R.M., Cook R.S., Morrison W.I., Hensen E., van Oirschot J.T., Keil G. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV. J. Gen. Virol. 1998, 79(Pt 7):1759-1767.
115. Taylor G., Stott E.J., Wertz G., Ball A. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice. J. Gen. Virol. 1991, 72(Pt. 1):125-130.
116. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J. Virol. 1995, 69:6658-6664.
117. Taylor G., Wyld S., Valarcher J.F., Guzman E., Thom M., Widdison S., Buchholz U.J. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. J. Gen. Virol. 2014, 95:1244-1254.
118. Thomas L.H., Cook R.S., Howard C.J., Gaddum R.M., Taylor G. Influence of selective T-lymphocyte depletion on the lung pathology of gnotobiotic calves and the distribution of different T-lymphocyte subsets following challenge with bovine respiratory syncytial virus. Res. Vet. Sci. 1996, 61:38-44.
119. Thomas L.H., Cook R.S., Wyld S.G., Furze J.M., Taylor G. Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus. J. Infect. Dis. 1998, 177:874-880.
120. Tregoning J.S., Yamaguchi Y., Harker J., Wang B., Openshaw P.J. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 2008, 82:4115-4124.
121. Triantafilou K., Kar S., Vakakis E., Kotecha S., Triantafilou M. Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 2013, 68:66-75.
122. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2001, 2:732-738.
123. Valarcher J.F., Furze J., Wyld S., Cook R., Conzelmann K.K., Taylor G. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol. 2003, 77:8426-8439.
124. Valarcher J.F., Taylor G. Bovine respiratory syncytial virus infection. Vet. Res. 2007, 38:153-180.
125. Van der Poel W.H., Brand A., Kramps J.A., Van Oirschot J.T. Respiratory syncytial virus infections in human beings and in cattle. J. Infect. 1994, 29:215-228.
126. Viuff B., Uttenthal A., Tegtmeier C., Alexandersen S. Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization. Vet. Pathol. 1996, 33:383-390.
127. Welliver T.P., Reed J.L., Welliver R.C. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr. Infect. Dis. J. 2008, 27:S92-S96.
128. Werling D., Collins R.A., Taylor G., Howard C.J. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus. J. Leukoc. Biol. 2002, 72:297-304.
129. Werling D., Koss M., Howard C.J., Taylor G., Langhans W., Hope J.C. Role of bovine chemokines produced by dendritic cells in respiratory syncytial virus-induced T cell proliferation. Vet. Immunol. Immunopathol. 2002, 87:225-233.
130. West K., Petrie L., Haines D.M., Konoby C., Clark E.G., Martin K., Ellis J.A. The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves. Vaccine 1999, 17:809-820.
131. Willcocks S., Offord V., Seyfert H.M., Coffey T.J., Werling D. Species-specific PAMP recognition by TLR2 and evidence for species-restricted interaction with Dectin-1. J. Leukoc. Biol. 2013, 94:449-458.
132. Williams J.V., Weitkamp J.H., Blum D.L., LaFleur B.J., Crowe J.E. The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations. Mol. Immunol. 2009, 47:407-414.
133. Windeyer M.C., Leslie K.E., Godden S.M., Hodgins D.C., Lissemore K.D., LeBlanc S.J. The effects of viral vaccination of dairy heifer calves on the incidence of respiratory disease, mortality, and growth. J. Dairy Sci. 2012, 95:6731-6739.
134. Yen H.H., Scheerlinck J.P., Gekas S., Sutton P. A sheep cannulation model for evaluation of nasal vaccine delivery. Methods 2006, 38:117-123.
135. Yen H.H., Wee J.L., Snibson K.J., Scheerlinck J.P. Thoracic duct cannulation without thoracotomy in sheep: a method for accessing efferent lymph from the lung. Vet. Immunol. Immunopathol. 2009, 129:76-81.